QUINOA SAPONIN COMPOSITIONS AND METHODS OF USE
    4.
    发明申请
    QUINOA SAPONIN COMPOSITIONS AND METHODS OF USE 审中-公开
    QUINOA SAPONIN组合物和使用方法

    公开(公告)号:WO1996003998A1

    公开(公告)日:1996-02-15

    申请号:PCT/CA1995000442

    申请日:1995-07-31

    CPC classification number: A61K36/185 A61K36/73 A61K2300/00

    Abstract: Novel Quinoa saponin pharmaceutical compositions are disclosed. The compositions are useful as immunological adjuvants, to stimulate nonspecific immunity, as well as to enhance an immunological response to a selected antigen. The Quinoa saponin compositions can also be used to enhance mucosal absorption of a drug administered therewith.

    Abstract translation: 公开了新的藜麦皂苷药物组合物。 该组合物可用作免疫佐剂,以刺激非特异性免疫,以及增强对所选抗原的免疫应答。 喹啉皂苷组合物也可用于增强与其一起施用的药物的粘膜吸收。

    ACUTE PHASE PROTEINS FOR DETECTION AND PROGNOSIS OF INFECTION AND TISSUE DAMAGE
    5.
    发明申请
    ACUTE PHASE PROTEINS FOR DETECTION AND PROGNOSIS OF INFECTION AND TISSUE DAMAGE 审中-公开
    用于检测和预防感染和组织损伤的急性期相关蛋白

    公开(公告)号:WO1993009142A1

    公开(公告)日:1993-05-13

    申请号:PCT/CA1992000476

    申请日:1992-11-06

    CPC classification number: C07K14/47 C07K14/811 C07K16/18

    Abstract: Acute phase proteins and antibodies thereto are disclosed, as well as methods of determining the presence and severity of infection and tissue damage by testing for these proteins. 17.5 kDa, 23 kDa and 37 kDa proteins have been identified in bovine subjects suffering from both infection and chemically induced tissue damage. The proteins are indicative of the severity and prognosis of disease. Antibodies thereto are useful in diagnostic assays.

    Abstract translation: 公开了急性期蛋白质及其抗体,以及通过测试这些蛋白质来确定感染和组织损伤的存在和严重程度的方法。 已经在感染和化学诱导的组织损伤的牛受试者中鉴定了17.5kDa,23kDa和37kDa的蛋白质。 蛋白质指示疾病的严重性和预后。 其抗体可用于诊断测定。

    VP6 ENCAPSULATED DRUG DELIVERY
    6.
    发明申请
    VP6 ENCAPSULATED DRUG DELIVERY 审中-公开
    VP6封装药物递送

    公开(公告)号:WO1992013568A1

    公开(公告)日:1992-08-20

    申请号:PCT/CA1992000029

    申请日:1992-01-29

    Abstract: Compositions and methods for preparing and delivering encapsulated biologically active agents to specific cell types are disclosed. Substances can be encapsulated in the VP6 inner capsid protein of rotavirus and delivered to selected cells, tissues and organs. Targeting agents can be linked to the surface of the VP6 sphere so that appropriate agents can be delivered to preselected cells and tissue types.

    Abstract translation: 公开了用于制备和递送包封的生物活性剂到特定细胞类型的组合物和方法。 物质可以封装在轮状病毒的VP6内衣壳蛋白中,并被递送到选定的细胞,组织和器官。 靶向剂可以连接到VP6球体的表面,使得适当的药剂可以递送到预选的细胞和组织类型。

Patent Agency Ranking